Welcome to our dedicated page for TTAN news (Ticker: TTAN), a resource for investors and traders seeking the latest updates and insights on TTAN stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect TTAN's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of TTAN's position in the market.
ServiceTitan announced the pricing of its initial public offering (IPO) of 8,800,000 shares of Class A common stock at $71.00 per share. The company granted underwriters a 30-day option to purchase up to an additional 1,320,000 shares. Trading is expected to begin on December 12, 2024, on the Nasdaq Global Select Market under the ticker symbol TTAN.
The offering, set to close on December 13, 2024, is led by Goldman Sachs and Morgan Stanley as lead book-running managers, with Wells Fargo Securities and Citigroup serving as additional book-running managers. Several other firms are participating as passive bookrunners and co-managers.
